Stock JCT-R JACK CHIA INDUSTRIES (THAILAND)
Add to a list
To use this feature you must be a member
Log inSign up

Financials Jack Chia Industries (Thailand) Thailand S.E.

Equities

JCT-R

TH0204010R16

Pharmaceuticals

End-of-day quote Thailand S.E.
Other stock markets
 03:30:00 17/05/2024 am IST 		5-day change 1st Jan Change
80.25 THB 0.00% Intraday chart for Jack Chia Industries (Thailand) -0.31% -0.31%
14/05 Jack Chia Industries Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
27/02 Jack Chia Industries Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 1,127 1,144 1,090 1,080 1,063 1,087
Enterprise Value (EV) 1 831.5 842.4 729.3 674 591.5 828.1
P/E ratio 12.6 x 12.6 x 16.2 x 16.5 x 12 x 11.4 x
Yield 5.03% 4.96% 4.33% 4.38% 5.08% 5.28%
Capitalization / Revenue 1.35 x 1.27 x 1.36 x 1.52 x 1.42 x 1.2 x
EV / Revenue 1 x 0.94 x 0.91 x 0.95 x 0.79 x 0.91 x
EV / EBITDA 6.27 x 5.99 x 7.31 x 6.97 x 4.57 x 6.19 x
EV / FCF 15.2 x 22.6 x 7.16 x 9.67 x 4.79 x -10.6 x
FCF Yield 6.57% 4.43% 14% 10.3% 20.9% -9.44%
Price to Book 0.97 x 0.96 x 0.91 x 0.86 x 0.81 x 0.81 x
Nbr of stocks (in thousands) 13,500 13,500 13,500 13,500 13,500 13,500
Reference price 2 83.50 84.75 80.75 80.00 78.75 80.50
Announcement Date 27/02/19 24/02/20 23/02/21 28/02/22 01/03/23 27/02/24
1THB in Million2THB
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 832.9 897.6 801.9 712.2 746.4 905.7
EBITDA 1 132.6 140.6 99.8 96.66 129.3 133.9
EBIT 1 108 116.9 74.69 74.33 108.9 114.4
Operating Margin 12.97% 13.03% 9.31% 10.44% 14.59% 12.64%
Earnings before Tax (EBT) 1 105.3 108.1 81.44 79.56 109.8 116.4
Net income 1 89.68 90.71 67.32 65.5 88.42 95.13
Net margin 10.77% 10.11% 8.39% 9.2% 11.85% 10.5%
EPS 2 6.643 6.719 4.986 4.852 6.550 7.047
Free Cash Flow 1 54.65 37.34 101.8 69.68 123.5 -78.16
FCF margin 6.56% 4.16% 12.69% 9.78% 16.55% -8.63%
FCF Conversion (EBITDA) 41.21% 26.56% 102.01% 72.09% 95.48% -
FCF Conversion (Net income) 60.94% 41.17% 151.22% 106.38% 139.66% -
Dividend per Share 2 4.200 4.200 3.500 3.500 4.000 4.250
Announcement Date 27/02/19 24/02/20 23/02/21 28/02/22 01/03/23 27/02/24
1THB in Million2THB
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 296 302 361 406 472 259
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 54.6 37.3 102 69.7 123 -78.2
ROE (net income / shareholders' equity) 7.83% 7.7% 5.64% 5.34% 6.9% 7.17%
ROA (Net income/ Total Assets) 5.2% 5.46% 3.4% 3.27% 4.44% 4.51%
Assets 1 1,724 1,663 1,979 2,004 1,990 2,109
Book Value Per Share 2 86.10 88.30 88.60 93.30 96.70 99.70
Cash Flow per Share 2 11.50 11.20 16.50 9.280 16.40 5.700
Capex 1 21.5 19.1 13.3 11.3 10.2 14.9
Capex / Sales 2.58% 2.12% 1.66% 1.59% 1.37% 1.64%
Announcement Date 27/02/19 24/02/20 23/02/21 28/02/22 01/03/23 27/02/24
1THB in Million2THB
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.09% 69TCr
NOVO NORDISK A/S Stock Novo Nordisk A/S
+29.39% 58TCr
JOHNSON & JOHNSON Stock Johnson & Johnson
-1.34% 37TCr
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 33TCr
ABBVIE INC. Stock AbbVie Inc.
+7.39% 29TCr
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.25% 24TCr
ROCHE HOLDING AG Stock Roche Holding AG
-3.03% 21TCr
NOVARTIS AG Stock Novartis AG
+10.02% 21TCr
AMGEN INC. Stock Amgen Inc.
+8.49% 17TCr
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. JCT Stock
  4. JCT-R Stock
  5. Financials Jack Chia Industries (Thailand)
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW